Literature DB >> 13159064

The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis.

R G BLOCH, A S DOONEIEF, A S BUCHBERG, S SPELLMAN.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh:

Substances:

Year:  1954        PMID: 13159064     DOI: 10.7326/0003-4819-40-5-881

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

Review 1.  Amine neurochemistry and aggression in crayfish.

Authors:  Jules B Panksepp; Zhaoxia Yue; Catherine Drerup; Robert Huber
Journal:  Microsc Res Tech       Date:  2003-02-15       Impact factor: 2.769

2.  Hepatitis associated with iproniazid (marsilid); report of 3 cases.

Authors:  H G LEVIN; J E BERK; L J PAUL; C BERMAN
Journal:  Am J Dig Dis       Date:  1959-04

Review 3.  Forced swimming test in mice: a review of antidepressant activity.

Authors:  Benoit Petit-Demouliere; Franck Chenu; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

4.  Antidepressants in the general hospital.

Authors:  A J Gelenberg
Journal:  Can Med Assoc J       Date:  1979-06-09       Impact factor: 8.262

5.  Monoamine oxidase inhibitors: clinical review.

Authors:  R A Remick; C Froese
Journal:  Can Fam Physician       Date:  1990-06       Impact factor: 3.275

Review 6.  Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.

Authors:  M Mayersohn; T W Guentert
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

Review 7.  Drug-induced mania.

Authors:  M Peet; S Peters
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 8.  Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.

Authors:  D L Sultzer; J L Cummings
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.